Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy.
Wendtner
C M
CM
Medizinische Klinik III, Klinikum Grosshadern, Germany.
Schmitt
B
B
Wilhelm
M
M
Dreger
P
P
Montserrat
E
E
Emmerich
B
B
Hallek
M
M
D001424:Bacterial Infections / Q000517:prevention & control; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D014740:Vidarabine; C024352:fludarabine